Catalina Capital Group’s Thermo Fisher Scientific TMO Stock Holding History

Catalina Capital Group’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-881	Closed	-$458K	–	345
2024 Q4	$458K	Sell	881 -163	-16%	-$89.6K	0.15%	137
2024 Q3	$646K	Buy	1,044 +149	+17%	+$88.2K	0.22%	101
2024 Q2	$495K	Buy	895 +71	+9%	+$40.7K	0.19%	118
2024 Q1	$479K	Buy	+824	New	+$462K	0.2%	108

Other funds holding TMO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Catalina Capital Group's TMO Position: Q1 2025 in Review

Catalina Capital Group sold out of Thermo Fisher Scientific (TMO) in Q1 2025, closing a stake of 881 shares — an estimated $458K sold.

Catalina Capital Group first reported a position in TMO in Q1 2024 and held it in 4 quarters. The position peaked at $646K in Q3 2024. 2,570 funds tracked by Wall St. Rank hold TMO as of Q1 2025.

Catalina Capital Group reported no remaining Thermo Fisher Scientific position as of Q1 2025 after selling out during the quarter.
Catalina Capital Group sold 881 Thermo Fisher Scientific shares in Q1 2025, an estimated $458K.
Catalina Capital Group first reported a position in Thermo Fisher Scientific in Q1 2024 and held it in 4 quarters.
Catalina Capital Group's Thermo Fisher Scientific position peaked at $646K in Q3 2024.
2,570 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2025.

Based on Catalina Capital Group's 13F filing for Q1 2025, filed 21 Apr 2025.